Fed. Circ. Lifts Injunction On Hanmi's Generic Nexium
The Federal Circuit vacated its prior temporary injunction in an order dated Sept. 30, allowing Hanmi’s drug, a 505(b)2 NDA esomeprazole strontium product, to be launched during the appeal of a New Jersey federal court’s claims constructions of the patents-at-issue.
“The temporary injunction is vacated,” the Federal Circuit...
To view the full article, register now.